These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial. Bailey C; Scott LJ; Rogers CA; Reeves BC; Hamill B; Peto T; Chakravarthy U; Harding SP; Ophthalmology; 2019 Jan; 126(1):75-86. PubMed ID: 30301555 [TBL] [Abstract][Full Text] [Related]
43. Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39. Tisdale AK; Agrón E; Sunshine SB; Clemons TE; Ferris FL; Chew EY; JAMA Ophthalmol; 2019 May; 137(5):543-550. PubMed ID: 30896764 [TBL] [Abstract][Full Text] [Related]
44. Age-related macular degeneration (AMD): More than meets the eye. The role of multimodal imaging in today's management of AMD-A review. Guymer R; Wu Z Clin Exp Ophthalmol; 2020 Sep; 48(7):983-995. PubMed ID: 32741052 [TBL] [Abstract][Full Text] [Related]
45. Peripheral autofluorescence and clinical findings in neovascular and non-neovascular age-related macular degeneration. Tan CS; Heussen F; Sadda SR Ophthalmology; 2013 Jun; 120(6):1271-7. PubMed ID: 23433790 [TBL] [Abstract][Full Text] [Related]
46. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks. Burlina PM; Joshi N; Pekala M; Pacheco KD; Freund DE; Bressler NM JAMA Ophthalmol; 2017 Nov; 135(11):1170-1176. PubMed ID: 28973096 [TBL] [Abstract][Full Text] [Related]
50. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
51. Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis. Fisher DE; Klein BE; Wong TY; Rotter JI; Li X; Shrager S; Burke GL; Klein R; Cotch MF Ophthalmology; 2016 Jun; 123(6):1297-308. PubMed ID: 26896123 [TBL] [Abstract][Full Text] [Related]
52. Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study. Koizumi H; Yamamoto A; Ogasawara M; Maruko I; Hasegawa T; Itagaki K; Sekiryu T; Okada AA; Iida T Jpn J Ophthalmol; 2020 Jul; 64(4):338-345. PubMed ID: 32447586 [TBL] [Abstract][Full Text] [Related]
53. Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2. Keenan TD; Agrón E; Mares J; Clemons TE; van Asten F; Swaroop A; Chew EY; Ophthalmology; 2020 Nov; 127(11):1515-1528. PubMed ID: 32348832 [TBL] [Abstract][Full Text] [Related]
54. Prevalence and risk factors for age-related macular degeneration: Korean National Health and Nutrition Examination Survey 2008-2011. La TY; Cho E; Kim EC; Kang S; Jee D Curr Eye Res; 2014 Dec; 39(12):1232-9. PubMed ID: 24754248 [TBL] [Abstract][Full Text] [Related]
55. Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration. Chan CK; Beaulieu WT; Lujan BJ; Lalezary M; Lent-Schochet D; Lo T; Yiu G Transl Vis Sci Technol; 2023 Sep; 12(9):1. PubMed ID: 37656449 [TBL] [Abstract][Full Text] [Related]
56. The effect of non-neovascular age-related macular degeneration on face recognition performance. Taylor DJ; Smith ND; Binns AM; Crabb DP Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):815-821. PubMed ID: 29484559 [TBL] [Abstract][Full Text] [Related]
57. Prevalence of Undiagnosed Age-Related Macular Degeneration in Primary Eye Care. Neely DC; Bray KJ; Huisingh CE; Clark ME; McGwin G; Owsley C JAMA Ophthalmol; 2017 Jun; 135(6):570-575. PubMed ID: 28448669 [TBL] [Abstract][Full Text] [Related]
58. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study. Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of Age-Related Macular Degeneration in Portugal: The Coimbra Eye Study - Report 1. Cachulo Mda L; Lobo C; Figueira J; Ribeiro L; Laíns I; Vieira A; Nunes S; Costa M; Simão S; Rodrigues V; Vilhena N; Cunha-Vaz J; Silva R Ophthalmologica; 2015; 233(3-4):119-27. PubMed ID: 25677077 [TBL] [Abstract][Full Text] [Related]
60. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study. Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]